Literature DB >> 12430874

Molecular mechanisms of lymphomagenesis through transcriptional disregulation by chromosome translocation.

Masao Seto1.   

Abstract

Chromosome translation plays an important role for lymphomagenesis. Transcriptional disregulation type of chromosome translocation involves a majority of B-cell lymphoma. These include BCL1/cyclin D1 translocation in mantle cell lymphoma, BCL2 in follicular lymphoma and BCL6 in diffuse large B-cell lymphoma. It is known that the transcriptional disregulation type causes aberrant gene expression at the stages where those genes are down-regulated in normal counterpart cells. Normal B-cells at mantle zone stage down-regulate the expression of BCL1 gene and become resting in cell cycle. However, BCL1 expression from translocated allele with immunoglobulin gene is not down-regulated at the mantle zone stage, preventing cells from entering in resting state, and puts cells in cell cycle, leading to development of mantle cell lymphoma. BCL2 expression from altered allele also keeps its expression at the germinal center stage where normal counterpart cells down-regulate BCL2 expression, and makes cells to resist apoptosis, leading to development of follicular lymphoma. The same scenario can apply to diffuse large B-cell lymphoma with BCL6 translocation; i.e. aberrant BCL6 expression at the post germinal center stage takes place where normal counterpart cells down-regulate BCL6 expression. Although a strong association of specific translocations with specific disease types is found, these translocations by themselves are not sufficient for malignant transformation. The factors other than chromosome translocations will be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12430874     DOI: 10.1007/bf03165276

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas.

Authors:  I S Lossos; C Y Okada; R Tibshirani; R Warnke; J M Vose; T C Greiner; R Levy
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

2.  Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK.

Authors:  Y Kagami; J Jung; Y S Choi; K Osumi; S Nakamura; Y Morishima; M Seto
Journal:  Leukemia       Date:  2001-01       Impact factor: 11.528

Review 3.  Germinal centres in T-cell-dependent antibody responses.

Authors:  Y J Liu; G D Johnson; J Gordon; I C MacLennan
Journal:  Immunol Today       Date:  1992-01

4.  Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.

Authors:  Y Yatabe; R Suzuki; K Tobinai; Y Matsuno; R Ichinohasama; M Okamoto; M Yamaguchi; J Tamaru; N Uike; Y Hashimoto; Y Morishima; T Suchi; M Seto; S Nakamura
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

5.  Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.

Authors:  W B Graninger; M Seto; B Boutain; P Goldman; S J Korsmeyer
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

6.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

Authors:  B H Ye; F Lista; F Lo Coco; D M Knowles; K Offit; R S Chaganti; R Dalla-Favera
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

7.  BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas.

Authors:  S Pittaluga; T A Ayoubi; I Wlodarska; M Stul; J J Cassiman; C Mecucci; H Van Den Berghe; W J Van De Ven; C De Wolf-Peeters
Journal:  J Pathol       Date:  1996-06       Impact factor: 7.996

8.  Selective usage of D-type cyclins in lymphoid malignancies.

Authors:  R Suzuki; H Kuroda; H Komatsu; Y Hosokawa; Y Kagami; M Ogura; S Nakamura; Y Kodera; Y Morishima; R Ueda; M Seto
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

9.  High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection.

Authors:  Andrea Albinger-Hegyi; Bernhard Hochreutener; Marie-Therese Abdou; Ivan Hegyi; María Teresa Dours-Zimmermann; Michael O Kurrer; Philipp U Heitz; Dieter R Zimmermann
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

10.  Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation.

Authors:  Y Tsujimoto; E Jaffe; J Cossman; J Gorham; P C Nowell; C M Croce
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

View more
  4 in total

1.  Apoptotic factors (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes.

Authors:  Taoufik Khalfaoui; Nuria Basora; Amel Ouertani-Meddeb
Journal:  J Mol Histol       Date:  2010-06-08       Impact factor: 2.611

Review 2.  Nonsense-mediated mRNA decay: The challenge of telling right from wrong in a complex transcriptome.

Authors:  Aparna Kishor; Sarah E Fritz; J Robert Hogg
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-05-26       Impact factor: 9.957

3.  hnRNP L-dependent protection of normal mRNAs from NMD subverts quality control in B cell lymphoma.

Authors:  Aparna Kishor; Zhiyun Ge; J Robert Hogg
Journal:  EMBO J       Date:  2018-12-07       Impact factor: 11.598

4.  Loss of Setd4 delays radiation-induced thymic lymphoma in mice.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Neta Schneider; Jingmei Liu; Lisa K Denzin; Chang S Chan; Subhajyoti De; Zhiyuan Shen
Journal:  DNA Repair (Amst)       Date:  2019-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.